Gene · 81502
HM13: histocompatibility minor 13
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. HM13: histocompatibility minor 13. Genes, record 81502. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/81502
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q8TCT9 | Signal peptide peptidase | 377 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents30
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 49150 | Q8TCT9 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 6781 | Q8TCT9 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 6568 | Q8TCT9 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 1974 | Q8TCT9 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 1974 | Q8TCT9 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 6568 | Q8TCT9 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 6781 | Q8TCT9 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 38438 | Q8TCT9 | Espacenet |
| US 11400116 B2 | 2022-08-02 | 5174 | Q8TCT9 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 141409 | Q8TCT9 | Espacenet |
1 to 10 of 30
See all 30 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants800
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | HM13 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 6 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| P30DK040561 | Boston Area Nutrition Obesity Research Center (NORC) | 4 | 2025 |
| P30ES005605 | Environmental Health Sciences Research Center | 4 | 2025 |
| P01AI120943 | Molecular Mechanisms of Filoviral-host Interactions | 3 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 3 | 2025 |
| K24HL137013 | Mentoring Research in Precision Medicine for Lung Disease | 2 | 2025 |
| K24HL138188 | Defining Pathways in COPD Patient Oriented Research | 2 | 2025 |
| P01CA097132 | Sphingolipids in Cancer Biology and Therapy | 2 | 2025 |
| P30CA016042 | Cancer Center Support Grant | 2 | 2025 |
1 to 10 of 800Source NIH's project files
See all 800 nih grantsPapers1,735
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Investigation of statistical properties of electromagnetic beams modulated by surface plasmon polaritons. | Opt Lett | 2026 | 42771393 | PubTator, text mining | PubMed |
| Chinese EFL learners' self-perceived pronunciation accuracy: a structural equation modeling study of L2 selves, foreign language anxiety, and speaking self-efficacy. | BMC Psychol | 2026 | 42351294 | PubTator, text mining | PubMed |
| Dimeric architecture and membrane thinning govern substrate recognition by human signal peptide peptidase. | Res Sq | 2026 | 42281969 | PubTator, text mining | PubMed |
| Investigating the Effects of a Novel Salmon-Derived Protein Peptide on Markers of Recovery From Exercise-Induced Muscle Damage. | Int J Sport Nutr Exerc Metab | 2026 | 42248424 | PubTator, text mining | PubMed |
| Integrated single-cell and bulk RNA-seq analysis reveals an NK-cell-related immune landscape and a prognostic signature for hepatocellular carcinoma. | Discov Oncol | 2026 | 42177711 | PubTator, text mining | PubMed |
| Hepatitis C virus p7 regulates Core protein processing via signal peptide peptidase to promote virion assembly. | J Virol | 2026 | 41995348 | PubTator, text mining | PubMed |
| Mechanistic insights and therapeutic potential of sphingosine‑1‑phosphate in the development of pulmonary fibrosis (Review). | Mol Med Rep | 2026 | 41860030 | PubTator, text mining | PubMed |
| Plasmons Enable Ultralow Threshold Solid-State Triplet Fusion Upconversion with a 2D Sensitizer. | Nano Lett | 2026 | 41838853 | PubTator, text mining | PubMed |
| Generation and characterization of human induced pluripotent stem cells from neuropathologically confirmed multiple system atrophy patient-derived fibroblasts. | Front Immunol | 2026 | 41808829 | PubTator, text mining | PubMed |
| Identification of isoform switching events linked with esophageal adenocarcinoma patient survival informs novel prognostic and therapeutic targets. | Cell Death Dis | 2026 | 41807370 | PubTator, text mining | PubMed |
1 to 10 of 1,735
See all 1,735 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/81502
GET https://conductscience.org/api/genes/v1/81502/patents?page=2